About Stemade Biotech
Stemade Biotech is a company based in Mumbai (India) founded in 2009 by Shailesh Gadre. It operates as a B2C and B2B. The company has 1 employees. Stemade Biotech offers products and services including Dental Stem Cell Banking and Health Care Plans. Stemade Biotech operates in a competitive market with competitors including BioEden, Tooth Bank and R-Crio, among others.
- Headquarter Mumbai, India
- Employees 1
- Founders Shailesh Gadre
- SectorsHealthcare
- Email••••••••
- Website stemade.com
- Social X
- Legal Name Stemade Biotech Private Limited
- Date of Incorporation 29 Jun, 2009
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹0.67 Cr
FY 2025 · +4% YoY
- Net Loss-₹0.18 Cr
FY 2025 · -26% margin
- EBITDA-₹0.01 Cr
FY 2025 · -1% margin
- Employee Count1
Associated legal entities of Stemade Biotech
Stemade Biotech operates through Stemade Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Stemade Biotech Private Limited CIN U93090MH2009PTC193622 | Active | 29 Jun 2009 | Mumbai, Maharashtra | ₹0.7 Cr | 1 | 2 | View details |
Products & Services of Stemade Biotech
Stemade Biotech offers a comprehensive portfolio of products and services, including Dental Stem Cell Banking and Health Care Plans.
Extracts and stores stem cells from teeth for future health treatments.
Provides affordable plans including stem cell banking options.
Board of directors of Stemade Biotech Private Limited (Stemade Biotech)
Stemade Biotech Private Limited is the primary company behind Stemade Biotech. The board of Stemade Biotech Private Limited currently have 2 directors; the longest-serving is Deepak Keshav Ghaisas, appointed in 2009.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Keshav Ghaisas DIN 00001811 | Director | 29 Jun 2009 | 17 yrs 3 mo | Stemade Biotech Private Limited |
| Shailesh Vishwas Gadre DIN 00140212 | Managing Director | 29 Jun 2009 | 17 yrs 3 mo | Stemade Biotech Private Limited |
People of Stemade Biotech
1 people are tracked at Stemade Biotech (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for Stemade Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Stemade Biotech
Figures of Stemade Biotech Private Limited, the primary company behind Stemade Biotech, for FY 2025. Revenue was ₹0.67 Cr (+4% year on year). Net loss was -₹0.18 Cr (-26% margin). EBITDA was -₹0.01 Cr (-1% margin). Revenue has grown at a compounded annual rate of +1% over three years and -15% over five years.
- ₹0.67 CrRevenue · FY 2025 · +4% YoY
- -₹0.18 CrNet loss · -26% margin
- -₹0.01 CrEBITDA · -1% margin
- ₹1.46 CrPaid-up capital
- 1Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- -15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Stemade Biotech Private Limited are on its company page.
Detailed financial statements for Stemade Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Stemade Biotech
Stemade Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioEden, Tooth Bank and R-Crio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioeden.com | 2006 | Huddersfield, United Kingdom | $319,894 | 10 | Stem cells from deciduous teeth are collected and cryopreserved. | |
| toothbank.com | 2010 | Brownsburg, United States | $200,000 | – | Dental stem cells are harvested from teeth and cryogenically preserved. | |
| r-crio.com | 2012 | Campinas, Brazil | – | – | Provides stem cell collection and storage services for regenerative therapies. |
Detailed competitors of Stemade Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stemade Biotech
Complete news archive for Stemade Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Stemade Biotech
10 companies that operate in the same segment as Stemade Biotech (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stemade Biotech
Stemade Biotech was founded in 2009.
Stemade Biotech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Stemade Biotech has 1 employees.
The primary company behind Stemade Biotech, Stemade Biotech Private Limited, reported revenue of ₹0.67 Cr for FY 2025, up 4% year on year.
Stemade Biotech Pvt. Ltd., based in Mumbai, India, provides dental stem cell banking by extracting cells from primary and wisdom teeth. They preserve these cells in cryogenic facilities for potential future medical treatments. The company offers affordable health care plans and insurance packages, serving families and individuals. Through this service, Stemade aims to support health security and innovative biotechnology applications in the Indian healthcare sector.
Stemade Biotech's top competitors include Tooth Bank, BioEden and R-Crio.
Stemade Biotech offers Dental Stem Cell Banking and Health Care Plans.
Stemade Biotech operates through Stemade Biotech Private Limited.
The legal entities of Stemade Biotech currently have 2 directors, including Deepak Keshav Ghaisas, Shailesh Vishwas Gadre.